3D bioprinting of complex tissues in vitro: state-of-the-art and future perspectives

Arch Toxicol. 2022 Mar;96(3):691-710. doi: 10.1007/s00204-021-03212-y. Epub 2022 Jan 10.

Abstract

The pharmacology and toxicology of a broad variety of therapies and chemicals have significantly improved with the aid of the increasing in vitro models of complex human tissues. Offering versatile and precise control over the cell population, extracellular matrix (ECM) deposition, dynamic microenvironment, and sophisticated microarchitecture, which is desired for the in vitro modeling of complex tissues, 3D bio-printing is a rapidly growing technology to be employed in the field. In this review, we will discuss the recent advancement of printing techniques and bio-ink sources, which have been spurred on by the increasing demand for modeling tactics and have facilitated the development of the refined tissue models as well as the modeling strategies, followed by a state-of-the-art update on the specialized work on cancer, heart, muscle and liver. In the end, the toxicological modeling strategies, substantial challenges, and future perspectives for 3D printed tissue models were explored.

Keywords: 3D printing; Biomaterials; In vitro model; Tissue engineering; Tissue model; Toxicity screening.

Publication types

  • Review

MeSH terms

  • Animals
  • Bioprinting / methods*
  • Extracellular Matrix / metabolism
  • Humans
  • Models, Biological*
  • Pharmacology / methods
  • Printing, Three-Dimensional*
  • Tissue Engineering / methods
  • Toxicology / methods